Ascendis Pharma A/S Announces Three Upcoming Investor Presentations
COPENHAGEN, Denmark, Aug. 24, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
COPENHAGEN, Denmark, Aug. 24, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
YCANTH™ is the first and only FDA-approved treatment for molluscum, a highly contagious viral skin…
YCANTH™ is the first and only FDA-approved treatment for molluscum, a highly contagious viral skin…
IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”)…
IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”)…
Patients dosed in Phase I/II trial, evaluating RECCE® 327 (R327) in patients with diabetic foot…
Patients dosed in Phase I/II trial, evaluating RECCE® 327 (R327) in patients with diabetic foot…
SAN DIEGO, Aug. 24, 2023 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics…
SAN DIEGO, Aug. 24, 2023 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics…
SANTA ANA, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (“NKGen” or the…
SANTA ANA, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (“NKGen” or the…
Fast Track Designation (FTD) is designed to accelerate the development and expedite the review of…
Fast Track Designation (FTD) is designed to accelerate the development and expedite the review of…
Agreement will supply Tb-161 for RAD 402, a potential next generation radiopharmaceutical for treatment of…
Agreement will supply Tb-161 for RAD 402, a potential next generation radiopharmaceutical for treatment of…
STOUGHTON, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
STOUGHTON, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
SAN DIEGO and GAINESVILLE, Ga., Aug. 24, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”;…
SAN DIEGO and GAINESVILLE, Ga., Aug. 24, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”;…
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the…